Norway
Global Fin Swe Nor Den Ger Cze Svk Pol Hun Nld Bel (nl) Bel (fr) USA
  • Logo
  • Produkter
  • Om oss
  • Nyheter
  • Kontakt oss
  • Bærekraft
  • Aidian Academy
  • Antibiotikaresistens
Søke
Logo
  • Pasientnær diagnostikk
  • Mikrobiologi
  • Hematologi
  • Molekylær mikrobiologi
  • Molekylær onkologi
  • Hygiene overvåking
  • RIA / kollagen
  • COVID-19
  • Andre
Pasientnær diagnostikk
  • QuikRead go
  • QuikRead 101
  • Aidian LF
  • Certest
  • Biosynex
  • Nova Biomedical
  • microINR
  • Acro™ Biotech
  • SD BIOSENSOR STANDARD™ F
  • bioLytical Laboratories INSTI®
  • Pulsar
  • GenSure
Les mer
QuikRead go
  • QuikRead go Instrument
  • QuikRead go easy CRP
  • QuikRead go CRP
  • QuikRead go CRP+Hb
  • QuikRead go wrCRP
  • QuikRead go wrCRP+Hb
  • QuikRead go HbA1c
  • QuikRead go Strep A
  • QuikRead go iFOBT
  • QuikRead go tilbehør
QuikRead go
Mikrobiologi
  • Uricult
  • Cultura M
  • MIKROGEN serologi
  • Meridian Immunoassays
  • Meridian Curian®
  • Reagena
  • Medac EIA
Les mer
Hematologi
  • Pixcell Medical – HemoScreen™
  • Norma Icon
Les mer
Molekylær mikrobiologi
  • ELITech Molecular Diagnostics
  • Meridian Alethia®
  • Meridian Revogene®
  • MIKROGEN molecular diagnostics
  • SD BIOSENSOR STANDARD™ M10
Les mer
Molekylær onkologi
  • Nucleix – Bladder EpiCheck®
Les mer
Hygiene overvåking
  • Easicult
  • Hygicult
  • Clean Card PRO
Les mer
RIA / kollagen
  • UniQ
Les mer
COVID-19
  • COVID-19-tester
Les mer
Andre
  • Grifols Promonitor®
  • Narkotika tester
Les mer
Logo
Lukk
  • Produkter
    • Pasientnær diagnostikk
      • QuikRead go
      • QuikRead 101
      • Aidian LF
      • Certest
      • Biosynex
      • Nova Biomedical
      • microINR
      • Acro™ Biotech
      • SD BIOSENSOR STANDARD™ F
      • bioLytical Laboratories INSTI®
      • Pulsar
      • GenSure
    • Mikrobiologi
      • Uricult
      • Cultura M
      • MIKROGEN serologi
      • Meridian Immunoassays
      • Meridian Curian®
      • Reagena
      • Medac EIA
    • Hematologi
      • Pixcell Medical – HemoScreen™
      • Norma Icon
    • Molekylær mikrobiologi
      • ELITech Molecular Diagnostics
      • Meridian Alethia®
      • Meridian Revogene®
      • MIKROGEN molecular diagnostics
      • SD BIOSENSOR STANDARD™ M10
    • Molekylær onkologi
      • Nucleix – Bladder EpiCheck®
    • Hygiene overvåking
      • Easicult
      • Hygicult
      • Clean Card PRO
    • RIA / kollagen
      • UniQ
    • COVID-19
      • COVID-19-tester
    • Andre
      • Grifols Promonitor®
      • Narkotika tester
  • Om oss
  • Nyheter
  • Kontakt oss
  • Bærekraft
  • Aidian Academy
  • Antibiotikaresistens

Populære produkter

Meridian Curian® Campy

Meridian Curian® Campy

Real-Time PCR Test Menu

Real-Time PCR Test Menu

ELITe BeGenius®

ELITe BeGenius®

Siste nytt

Se alt

Prepare for the Strep A season in the coming fall/winter

26. september 2023 | Nyheter, Produktnyheter

Get ready for flu season!

12. september 2023 | Nyheter, Produktnyheter

Free access clinical webinars on iMg, estimated plasma volume, fetal lactate, and many other topics

26. juni 2023 | Nyheter, Produktnyheter

  • Se alt
  • Ingen resultater
  • Loading...

Nyheter

Prepare for the Strep A season in the coming fall/winter

26. september 2023 | Nyheter, Produktnyheter

Get ready for flu season!

12. september 2023 | Nyheter, Produktnyheter

Tilbake til alle nyheter
17. april 2020
Nyheter,
AMR

Antimicrobial resistance (AMR) has a role in COVID-19

Antimicrobial resistance (AMR) has a role in COVID-19

Antimicrobial resistance (AMR) is an important threat to global health1. AMR should not be overlooked despite understandable focus on the ongoing COVID-19 pandemic. An increasing body of opinion indicates that AMR may have a role in COVID-192-4.

Firstly, a significant number of the deceased COVID-19 patients have had secondary bacterial infections like is common for other several viral infections5-9. In severe viral respiratory infections, the immune system is weakened, and respiratory system exposed to other pathogens. In such cases, if a hospitalized patient is infected with resistant bacteria, consequences can be fatal. There are indications of increase in resistant bacterial infections such as MRSA in hospitals during the outbreaks of novel emerging pathogens such as previous SARS epidemics10,11. It bears further investigation if the resistant bacteria have influenced the COVID-19 situation for example in Italy, where hospitals have been shown to have significant AMR-related problems12.

Secondly, prophylactic antibiotics are often used to prevent secondary bacterial infections of the hospitalized patients as is the case also in COVID-197,8,13-15. This can significantly increase the use of antibiotics during the pandemic and silently cause the emergence of resistant bacteria, as was recently commented by Prof. Anu Kantele from University of Helsinki4.

The actual role of antimicrobial resistance in COVID-19 may be revealed in the future. However, AMR as such is an important threat to global health although it develops more silently compared to COVID-19. The fight against AMR calls for collective global actions on various levels, as has now been rapidly done in COVID-19.1, 2, 16, 17.

References

  1. WHO. Global action plan on Antimicrobial Resistance 2015. Available at WHO: Global action plan on antimicrobial resistance 2015.
  2. Kirchhelle et al. Opinion: Antibiotic Resistance Could Lead to More COVID-19 Deaths. Scientific American 2020. April 1. https://blogs.scientificamerican.com/observations/antibiotic-resistance-could-lead-to-more-covid-19-deaths/?amp, accessed 15.4.2020
  3. Aftenposten. Derfor tar koronaviruset så mange liv i Italia | Erik Martiniussen. Article in Norwegian. https://www.aftenposten.no/article/ap-awEP27.html , accessed 15.4.2020
  4. Helsingin Sanomat. Antibioottien runsas käyttö saattaa selittää Italian koronavirus­kuolemien määrää. 5.4.2020. Article in Finnish. https://www.hs.fi/tiede/art-2000006464588.html, accessed 15.4.2020
  5. Wang L et al. Coronavirus Disease 2019 in elderly patients: characteristics and prognostic factors based on 4-week follow-up. J Infect. 2020. Mar 30. doi: 10.1016/j.jinf.2020.03.019.
  6. Li et al. Clinical characteristics of 25 death cases with COVID-19: a retrospectivereview of medical records in a single medical center, Wuhan, China. Int J Infect Dis 2020. doi: https://doi.org/10.1016/j.ijid.2020.03.053
  7. Zhou et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020; 395: 1054–62.
  8. Huang et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395: 497–506.
  9. Centers for Disease Control and Prevention (CDC). Bacterial coinfections in lung tissue specimens from fatal cases of 2009 pandemic influenza A (H1N1) - United States, May-August 2009. MMWR Morb Mortal Wkly Rep. 2009; 58(38):1071-4.
  10. Yap et al. Increase in methicillin-resistant Staphylococcus aureus acquisition rate and change in pathogen pattern associated with an outbreak of severe acute respiratory syndrome. Clin Infect Dis. 2004; 39(4):511-6.
  11. Chai et al. Paradoxical Increase in Methicillin-Resistant Staphylococcus aureus Acquisition Rates Despite Barrier Precautions and Increased Hand Washing Compliance during an Outbreak of Severe Acute Repiratory Syndrome. Clin Infect Dis. 2005; 40(4): 632–633.
  12. European Centre for Disease Prevention and Control. ECDC country visit to Italy to discuss antimicrobial resistance issues. Stockholm: ECDC; 2017.
  13. Cao et al. Clinical Features and Short-term Outcomes of 102 Patients with Corona Virus Disease 2019 in Wuhan, China. Clin Infect Dis. 2020 Apr 2. doi: 10.1093/cid/ciaa243.
  14. Lupia et al. 2019 novel coronavirus (2019-nCoV) outbreak: A new challenge. J Glob Antimicrob Resist. 2020 Mar 7; 21:22-27. doi: 10.1016/j.jgar.2020.02.021.
  15. Wang et al. Clinical Features of 69 Cases with Coronavirus Disease 2019 in Wuhan, China. Clin Infect Dis. 2020 Mar 16. doi: 10.1093/cid/ciaa272.
  16. WHO. Strategic preparedness and response plan for the new coronavirus14.4.2020. https://www.who.int/publications-detail/covid-19-strategy-update-13-april-2020, Accessed 15.4.2020
  17. PEW. The Invaluable Role of Antibiotics—in a Pandemic and Beyond, 15.4.2020. https://www.pewtrusts.org/en/research-and-analysis/articles/2020/04/15/the-invaluable-role-of-antibiotics-in-a-pandemic-and-beyond?amp=1&__twitter_impression=true, Accessed 17.4.2020
Share
Facebook
Twitter
E-post

Aidian Norway AS

Fredrik Selmers vei 6,
0663 Oslo

Forespørsler
info@aidian.no

Salg
ordre@aidian.no

(+47) 66 78 56 30

Fakturaadresser

Fakturaadresse
(kun pdf-format) 922183848@xbs-salo.com

MVA-ID 922 183 848

  • Kontakt oss
  • Personvern
    • Personvernregler
    • Personvernerklæring
    • Varsel om informasjonskapsler
    • Social Media Policy (in English)
    • Slette samtykke til direkte markedsføring
  • Aidian Academy
  • Karriere
  • Bærekraft
  • Produkter
    • QuikRead go
    • QuikRead 101
    • Aidian LF
    • Easicult
    • Hygicult
    • Clean Card PRO
    • Uricult
    • Cultura M
    • UniQ
    • Certest
    • Biosynex
    • Nova Biomedical
    • microINR
    • Acro™ Biotech
    • SD BIOSENSOR STANDARD™ F
    • bioLytical Laboratories INSTI®
    • Pulsar
    • GenSure
    • MIKROGEN serologi
    • Meridian Immunoassays
    • Meridian Curian®
    • Reagena
    • Medac EIA
    • Pixcell Medical
    • Norma Icon
    • ELITech Molecular Diagnostics
    • Meridian Alethia®
    • Meridian Revogene®
    • MIKROGEN molecular diagnostics
    • SD BIOSENSOR STANDARD™ M10
    • Nucleix
    • Grifols Promonitor®
    • COVID-19-tester
    • Narkotika tester
Copyright © 2023 Aidian

Dette nettstedet bruker informasjonskapsler

Vi bruker informasjonskapsler til å tilpasse innhold og annonser, til å analysere bruken av nettstedet og til å gjøre tjenestene våre bedre.

Administrer innstillinger

Nødvendige (Obligatorisk)

Informasjonskapsler som nettstedet trenger for å kunne fungere slik det skal. Dette omfatter informasjonskapsler som benyttes til å gi tilgang til sikre områder, og informasjonskapsler som benyttes til å beskytte mot ondsinnet datakode (CSRF). Vær oppmerksom på at Crafts standardinformasjonskapsler ikke samler inn personopplysninger eller sensitive opplysninger. Crafts standardinformasjonskapsler samler ikke inn IP-adresser. Informasjonen de lagrer, sendes ikke til Pixel & Tonic eller andre tredjeparter.
— CraftSessionId
Provider: this site
Expiration: Session
Description: Craft benytter PHP-økter til å opprettholde økter over flere nettforespørsler. Dette gjøres gjennom PHP-øktinformasjonskapselen. Craft har gitt informasjonskapselen standardnavnet «CraftSessionId», men den kan gis nytt navn via konfigurasjonsinnstillingen for phpSessionId. Denne informasjonskapselen utløper når økten utløper.
— *_identity
Provider: this site
Expiration: Persistent
Description: Når du logger på kontrollpanelet, mottar du en godkjenningsinformasjonskapsel som brukes til å opprettholde godkjenningsstatusen din. Navnet på informasjonskapselen får et langt, tilfeldig laget forledd, etterfulgt av _identity. Informasjonskapselen lagrer bare opplysninger som er nødvendige for å opprettholde en sikker og godkjent økt, og varer bare så lenge brukeren er godkjent i Craft.
— *_username
Provider: this site
Expiration: Persistent
Description: Dersom du har merket av La meg være pålogget under påloggingen, brukes denne informasjonskapselen til å huske brukernavnet til neste godkjenning.
— CRAFT_CSRF_TOKEN
Provider: this site
Expiration: Session
Description: Beskytter oss og deg som bruker mot angrep fra ondsinnet datakode (CSRF).

Statistikk

Statistikkinformasjonskapsler hjelper oss å forstå hvordan besøkende samhandler med nettsteder, gjennom å samle inn og formidle informasjon i anonym form.

Markedsføring

Markedsføringsinformasjonskapsler brukes til å spore besøkende over flere nettsteder. Formålet er å vise annonser som er relevante og engasjerende for den enkelte brukeren, og som dermed får større verdi for utgiverne og tredjepartsannonsørene.
Skjul detaljer